Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1922059666
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4401 W Memorial Rd, 2700
Oklahoma City, OK, 73134
Phone (405) 751-4343
Groups this clinician bills Medicare through
Medicare paid, 2024
$158K
5,293 services
Medicare patients, 2024
479
Average age 76
Drug cost, 2024
$7.3M
2,775 prescriptions
Company payments, 2025
$1,558
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jess F Armor was code 36415 (venipuncture blood collection), 1,703 times for 409 patients. In total Jess F Armor billed 5,293 services in 21 codes, and Medicare paid $158K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,703 | 409 | $8.54 | $15K |
| 85025 Blood Count | Office | 1,592 | 397 | $7.51 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 723 | 332 | $11.71 | $8,466 |
| 99214 Office E&M - Established | Office | 589 | 346 | $82.00 | $48K |
| 99215 Office E&M - Established | Office | 412 | 147 | $121.42 | $50K |
| 99205 Office E&M - New | Office | 57 | 57 | $154.27 | $8,794 |
| 99213 Office E&M - Established | Office | 48 | 46 | $61.02 | $2,929 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 16 | $55.45 | $1,996 |
| 99223 Hospital E&M - Initial | Facility | 34 | 29 | $125.91 | $4,281 |
| 38222 Other Organ Systems | Office | 22 | 22 | $115.86 | $2,549 |
| 99231 Hospital E&M - Subsequent | Facility | 21 | 15 | $35.00 | $735 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 11 | $77.00 | $1,386 |
| 99204 Office E&M - New | Office | 14 | 14 | $114.66 | $1,605 |
By year: 2022 $153K for 4,532 services; 2023 $159K for 4,430 services; 2024 $158K for 5,293 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,703 | 409 | $8.54 | $15K |
| 85025 Blood Count | 1,592 | 397 | $7.51 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Jess F Armor prescribed most often to Medicare patients was Eliquis (Apixaban), with 124 prescriptions and refills. In total Jess F Armor wrote 2,775 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 124 | 184 | 23 | $101K |
| Gabapentin Generic | 111 | 177 | 24 | $1,327 |
| Lenalidomide Generic | 106 | 106 | 15 | $1.5M |
| Levothyroxine Sodium Generic | 96 | 279 | 28 | $1,323 |
| Prednisone Generic | 84 | 119 | 26 | $615 |
| Ondansetron Odt Ondansetron | 81 | 81 | 34 | $936 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 78 | 78 | 24 | $1,129 |
| Abiraterone Acetate Generic | 74 | 76 | Under 11 | $91K |
| Valacyclovir Valacyclovir Hcl | 70 | 160 | 20 | $2,782 |
| Oxycodone Hcl Generic | 69 | 69 | 14 | $846 |
| Brukinsa Zanubrutinib | 63 | 63 | Under 11 | $934K |
| Pregabalin Generic | 59 | 65 | Under 11 | $893 |
| Imatinib Mesylate Generic | 56 | 56 | Under 11 | $18K |
| Dexamethasone Generic | 54 | 78 | 31 | $1,143 |
| Mirtazapine Generic | 53 | 77 | 13 | $609 |
Brand drugs: 619 claims; generic drugs: 2,156 claims; opioid claims: 282.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jess F Armor $1,558 ($1,558 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,071.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.